Fosalong Plus D Tablet

Adult dose

1 tablet (70 mg/2800 IU or 70 mg/5600 IU) of this medication should be taken once a week in the morning at least 30 minutes before intake of food, beverages, or other medications with a sufficient amount of water. Do not lie down for at least 30 minutes after taking and before the first intake of food. It should not be taken before bed or upon waking. If a dose is missed, take 1 tablet of this medication the next morning.

Child dose

Pediatric and adolescent (under 18 years old): Safety and efficacy have not been established.

This medication can irritate the gastrointestinal mucosa, causing upper gastrointestinal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosions, thus caution is needed during intake. In particular, do not lie down for at least 30 minutes after taking the medication, and it should be taken with a sufficient amount of water to reduce the risk of esophageal irritation. If symptoms such as dysphagia, odynophagia, pain behind the sternum, or heartburn occur, discontinue use immediately and consult a physician. This medication should not be administered to patients with esophageal motility disorders or those who cannot sit upright or stand for more than 30 minutes, to patients with hypersensitivity to the drug's components, to patients with hypocalcemia, or to patients with certain genetic metabolic disorders. While taking this medication, adverse reactions such as indigestion, abdominal pain, nausea, constipation, diarrhea, musculoskeletal pain, headache, dizziness, and taste disturbances may occur, so caution is required. This medication should be taken with a gap from calcium supplements and antacids, and the risk of gastrointestinal adverse reactions may increase when used in conjunction with aspirin. During pregnancy, there may be risks to the fetus, so it should be administered only after consulting a physician, and caution is also needed for nursing mothers. It is not recommended for use in children, and it is not advisable to administer to elderly patients or those with severely impaired renal function. In case of overdose, hypocalcemia, gastrointestinal adverse reactions, etc. may occur, so immediate contact with a medical institution is necessary, and inducing vomiting should be avoided while maintaining an upright position. This medication should be stored out of the reach of children, and transferring to another container should be avoided.

Serious side effects

Hives, severe swelling (angioedema), esophagitis, esophageal erosions, esophageal ulcers, and rarely esophageal strictures or perforations, severe allergic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, symptoms of hypocalcemia, severe edema, severe skin adverse reactions, severe cutaneous reactions, severe neurological symptoms (seizures, confusion, etc.), reports have included dizziness.

Mild side effects

Abdominal pain, nausea, indigestion, constipation, diarrhea, flatulence, acid reflux, esophageal ulcers, vomiting, dysphagia, abdominal bloating, gastritis, musculoskeletal (bone, muscle, or joint) pain, muscle cramps, headache, dizziness, taste disturbance, rash, itching, hair loss, nasopharyngitis

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It should be stored at room temperature between 1°C and 30°C, and kept in a location protected from direct light to maintain its efficacy.

Appearance

White to light yellow oblong tablet

Package unit

4 tablets (4 tablets/PTP x 1)